Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Alexander Burnett

Concepts (195)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Laparoscopy
7
2024
173
2.040
 Why?
Endometrial Neoplasms
8
2024
137
1.890
 Why?
Uterine Cervical Neoplasms
12
2022
276
1.710
 Why?
Lymph Node Excision
5
2024
131
1.520
 Why?
Neoplasm Staging
8
2024
746
0.910
 Why?
Obesity, Morbid
2
2023
78
0.900
 Why?
Natural Orifice Endoscopic Surgery
1
2023
4
0.890
 Why?
Whole-Body Irradiation
2
2014
132
0.850
 Why?
Gynecologic Surgical Procedures
4
2009
29
0.850
 Why?
Sentinel Lymph Node Biopsy
1
2024
118
0.850
 Why?
Metformin
2
2020
65
0.630
 Why?
Hypoglycemic Agents
2
2020
173
0.600
 Why?
Interleukin-11
2
2013
5
0.520
 Why?
Neoplasm Recurrence, Local
3
2016
629
0.480
 Why?
2-Pyridinylmethylsulfinylbenzimidazoles
1
2014
19
0.460
 Why?
Prescription Drugs
1
2014
37
0.450
 Why?
Hysterectomy
4
2023
88
0.440
 Why?
Uterine Neoplasms
7
2007
60
0.440
 Why?
Proton Pump Inhibitors
1
2014
83
0.440
 Why?
Radiation Tolerance
1
2014
84
0.430
 Why?
Radiation-Protective Agents
1
2013
72
0.420
 Why?
Obesity
2
2016
1121
0.410
 Why?
Robotics
2
2010
41
0.400
 Why?
Female
32
2024
27081
0.390
 Why?
Organotechnetium Compounds
1
2011
7
0.370
 Why?
Lymphedema
1
2011
46
0.360
 Why?
Vulvar Neoplasms
1
2011
58
0.350
 Why?
Lower Extremity
1
2011
92
0.340
 Why?
Radiopharmaceuticals
1
2011
204
0.340
 Why?
Carcinoma, Squamous Cell
2
2011
326
0.330
 Why?
Cystadenocarcinoma, Papillary
5
2006
14
0.320
 Why?
Humans
34
2024
50503
0.300
 Why?
Fertility
2
2009
28
0.290
 Why?
Adult
19
2024
13577
0.290
 Why?
Retroperitoneal Space
2
2024
27
0.290
 Why?
Aged
16
2024
9741
0.280
 Why?
Retrospective Studies
5
2023
6263
0.280
 Why?
Vagina
2
2023
43
0.280
 Why?
Middle Aged
18
2024
12611
0.280
 Why?
Cervix Uteri
1
2006
42
0.250
 Why?
Adenocarcinoma
1
2009
397
0.250
 Why?
Topotecan
1
2005
17
0.240
 Why?
Polyethylene Glycols
1
2005
86
0.230
 Why?
Genital Neoplasms, Female
1
2004
41
0.220
 Why?
Postoperative Complications
1
2011
1033
0.220
 Why?
Ovarian Neoplasms
4
2014
450
0.220
 Why?
Feasibility Studies
2
2024
390
0.210
 Why?
Uterus
1
2023
85
0.210
 Why?
Doxorubicin
1
2005
236
0.210
 Why?
Lymph Nodes
1
2004
257
0.200
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2007
1000
0.200
 Why?
Gene Expression Regulation, Neoplastic
6
2011
833
0.200
 Why?
Aged, 80 and over
5
2016
3226
0.180
 Why?
Prospective Studies
3
2024
2378
0.170
 Why?
Intestines
2
2013
172
0.170
 Why?
Carcinoma
2
2011
137
0.140
 Why?
Cell Proliferation
2
2020
985
0.140
 Why?
Antineoplastic Agents
2
2007
1172
0.140
 Why?
Cancer Vaccines
3
2014
80
0.140
 Why?
Dendritic Cells
3
2014
135
0.140
 Why?
Kruppel-Like Transcription Factors
2
2020
34
0.130
 Why?
Cystadenocarcinoma, Serous
3
2005
71
0.130
 Why?
Enterotoxins
2
2007
12
0.130
 Why?
Pregnancy
1
2023
2452
0.130
 Why?
Aromatase Inhibitors
2
2007
17
0.130
 Why?
Nitriles
2
2007
52
0.130
 Why?
Kallikreins
2
2006
18
0.130
 Why?
Mice
4
2014
5687
0.120
 Why?
Triazoles
2
2007
113
0.120
 Why?
Receptor, erbB-2
2
2005
75
0.120
 Why?
Neoplasms
1
2005
1251
0.120
 Why?
Medical Oncology
2
2006
98
0.120
 Why?
Lethal Dose 50
1
2014
12
0.120
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2014
16
0.110
 Why?
Hematopoiesis
1
2014
72
0.110
 Why?
Hydrogen-Ion Concentration
1
2014
168
0.110
 Why?
Ascites
1
2014
28
0.110
 Why?
Safety
1
2014
77
0.110
 Why?
Survival Analysis
2
2013
661
0.110
 Why?
Stomach
1
2014
81
0.110
 Why?
Spectrometry, Fluorescence
1
2013
46
0.110
 Why?
Carcinoma, Endometrioid
2
2010
38
0.100
 Why?
CD4-Positive T-Lymphocytes
1
2014
158
0.100
 Why?
Incidence
1
2016
1032
0.100
 Why?
Administration, Oral
1
2013
434
0.100
 Why?
Papillomaviridae
3
2013
103
0.100
 Why?
Animals
5
2014
13124
0.100
 Why?
Cytokines
1
2014
606
0.090
 Why?
Arkansas
1
2016
1985
0.080
 Why?
Cerclage, Cervical
1
2009
8
0.080
 Why?
Treatment Outcome
3
2011
5283
0.080
 Why?
Estrogens
1
2011
226
0.080
 Why?
Gene Amplification
2
2005
56
0.080
 Why?
Genes, erbB-2
2
2005
8
0.080
 Why?
Male
4
2014
25907
0.070
 Why?
Carcinoma, Papillary
2
2005
47
0.070
 Why?
Membrane Proteins
2
2007
332
0.070
 Why?
Melanoma
1
2011
280
0.070
 Why?
Intestinal Diseases
1
2007
26
0.070
 Why?
Leiomyosarcoma
1
2007
20
0.070
 Why?
Clostridium perfringens
1
2007
6
0.070
 Why?
Carcinosarcoma
1
2007
18
0.070
 Why?
Radiation Injuries, Experimental
1
2007
80
0.070
 Why?
Endometrium
2
2020
40
0.070
 Why?
Infertility, Female
1
2006
18
0.060
 Why?
Oncogene Proteins, Viral
1
2005
52
0.060
 Why?
Fellowships and Scholarships
1
2006
120
0.060
 Why?
Dysgerminoma
1
2004
3
0.060
 Why?
Medroxyprogesterone Acetate
1
2004
6
0.060
 Why?
Patient Selection
1
2006
259
0.060
 Why?
Gynecology
1
2004
48
0.060
 Why?
Interleukin-6
1
2005
261
0.060
 Why?
Immunotherapy, Adoptive
1
2005
163
0.060
 Why?
Lymphatic Metastasis
1
2004
222
0.050
 Why?
Drug Therapy, Combination
1
2005
384
0.050
 Why?
Antibodies, Monoclonal
1
2007
462
0.050
 Why?
Adolescent
4
2013
6443
0.050
 Why?
Immunohistochemistry
4
2007
957
0.050
 Why?
Immunotherapy
1
2005
235
0.050
 Why?
DNA-Binding Proteins
1
2005
418
0.050
 Why?
Cells, Cultured
3
2014
1571
0.050
 Why?
Education, Medical, Graduate
1
2004
217
0.050
 Why?
Lung Neoplasms
1
2007
601
0.050
 Why?
Gene Expression Profiling
1
2005
1025
0.040
 Why?
Preoperative Period
1
2020
48
0.040
 Why?
PTEN Phosphohydrolase
1
2020
53
0.040
 Why?
Receptors, Progesterone
1
2020
64
0.040
 Why?
Estrogen Receptor alpha
1
2020
88
0.040
 Why?
Cell Line, Tumor
3
2007
1398
0.040
 Why?
Pilot Projects
1
2020
698
0.040
 Why?
Claudin-3
2
2007
5
0.030
 Why?
Claudin-4
2
2007
7
0.030
 Why?
Lymphocyte Activation
2
2007
164
0.030
 Why?
Mice, SCID
2
2007
178
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
2
2006
234
0.030
 Why?
In Situ Hybridization, Fluorescence
2
2005
231
0.030
 Why?
Apoptosis
1
2020
1097
0.030
 Why?
Coculture Techniques
1
2014
142
0.030
 Why?
p38 Mitogen-Activated Protein Kinases
1
2014
93
0.030
 Why?
Human Umbilical Vein Endothelial Cells
1
2014
90
0.030
 Why?
Combined Modality Therapy
2
2007
641
0.030
 Why?
Optics and Photonics
1
2013
10
0.030
 Why?
Antigens, Neoplasm
1
2014
148
0.030
 Why?
Drug Resistance, Neoplasm
2
2005
316
0.030
 Why?
Spectrum Analysis
1
2013
70
0.030
 Why?
Uterine Cervical Dysplasia
1
2013
49
0.030
 Why?
RNA, Messenger
2
2005
1089
0.020
 Why?
Early Detection of Cancer
1
2013
163
0.020
 Why?
Papillomavirus Infections
1
2013
168
0.020
 Why?
Gene Silencing
1
2011
115
0.020
 Why?
Prognosis
2
2005
1978
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2007
12
0.020
 Why?
Mast Cells
1
2007
54
0.020
 Why?
Neoplasm Transplantation
1
2007
86
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
 Why?
Remission Induction
1
2007
208
0.020
 Why?
Transforming Growth Factor beta
1
2007
136
0.020
 Why?
Lymphocytes
1
2007
149
0.020
 Why?
Intestinal Mucosa
1
2007
216
0.020
 Why?
Recombinant Proteins
1
2007
476
0.020
 Why?
Hypersensitivity, Delayed
1
2005
19
0.020
 Why?
Papillomavirus E7 Proteins
1
2005
31
0.020
 Why?
Sampling Studies
1
2005
36
0.020
 Why?
Antigens, Viral
1
2005
42
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2007
226
0.020
 Why?
Probability
1
2005
164
0.020
 Why?
Injections, Intraperitoneal
1
2005
59
0.020
 Why?
Paraffin Embedding
1
2005
51
0.020
 Why?
Statistics, Nonparametric
1
2005
192
0.020
 Why?
Biopsy, Needle
1
2005
178
0.010
 Why?
Carboplatin
1
2004
54
0.010
 Why?
Etoposide
1
2004
77
0.010
 Why?
Xenograft Model Antitumor Assays
1
2005
212
0.010
 Why?
B-Lymphocytes
1
2005
171
0.010
 Why?
Flow Cytometry
1
2007
474
0.010
 Why?
Chemotherapy, Adjuvant
1
2004
121
0.010
 Why?
Receptors, Cell Surface
1
2005
116
0.010
 Why?
Tumor Cells, Cultured
1
2005
457
0.010
 Why?
Polymerase Chain Reaction
1
2005
449
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
572
0.010
 Why?
Proportional Hazards Models
1
2005
415
0.010
 Why?
Rats, Sprague-Dawley
1
2007
1585
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2005
405
0.010
 Why?
Young Adult
1
2013
4102
0.010
 Why?
T-Lymphocytes
1
2005
325
0.010
 Why?
Clinical Competence
1
2006
398
0.010
 Why?
Sensitivity and Specificity
1
2005
859
0.010
 Why?
Case-Control Studies
1
2006
1156
0.010
 Why?
Survival Rate
1
2005
909
0.010
 Why?
Disease-Free Survival
1
2003
444
0.010
 Why?
Regression Analysis
1
2003
382
0.010
 Why?
Age Factors
1
2005
1110
0.010
 Why?
Rats
1
2007
3292
0.010
 Why?
Risk Assessment
1
2005
1270
0.010
 Why?
Child
1
2004
6906
0.010
 Why?
Burnett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (195) concept(s)
_
Co-Authors Expand Description
See all (7) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department